2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary …

J Knuuti, W Wijns, A Saraste, D Capodanno… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

2020 ACC/AHA clinical performance and quality measures for adults with heart failure: a report of the American College of Cardiology/American Heart Association …

PA Heidenreich, GC Fonarow, K Breathett… - … Quality and Outcomes, 2020 - Am Heart Assoc
The American Heart Association requests that this document be cited as follows:
Heidenreich PA, Fonarow GC, Breathett K, Jurgens CY, Pisani BA, Pozehl BJ, Spertus JA …

[HTML][HTML] Хроническая сердечная недостаточность. Клинические рекомендации 2020

СН Терещенко, АС Галявич, ТМ Ускач… - Российский …, 2020 - cyberleninka.ru
КТИ—кардиоторакальный индекс КШ—коронарное шунтирование ЛЖ—левый
желудочек МНО—международное нормализованное отношение МРТ—магнитно …

β-Adrenergic receptor, an essential target in cardiovascular diseases

DC Ali, M Naveed, A Gordon, F Majeed, M Saeed… - Heart failure …, 2020 - Springer
Abstract β-Adrenergic receptors (βARs) belong to a large family of cell surface receptors
known as G protein–coupled receptors (GPCRs). They are coupled to Gs protein (Gαs) for …

Guideline‐directed medical therapy for heart failure does not exist: a non‐judgmental framework for describing the level of adherence to evidence‐based drug …

M Packer, M Metra - European Journal of Heart Failure, 2020 - Wiley Online Library
Numerous guideline documents have issued recommendations to clinicians concerning the
treatment of chronic heart failure and a reduced ejection fraction. However, guidelines do …

[HTML][HTML] Liposomal resveratrol and/or carvedilol attenuate doxorubicin-induced cardiotoxicity by modulating inflammation, oxidative stress and S100A1 in rats

AM Alanazi, L Fadda, A Alhusaini, R Ahmad, IH Hasan… - Antioxidants, 2020 - mdpi.com
Doxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important
chemotherapeutic agents for different types of cancers. DOX treatment is associated with …

Cancer mortality in trials of heart failure with reduced ejection fraction: a systematic review and meta‐analysis

G Tini, E Bertero, A Signori, MP Sormani… - Journal of the …, 2020 - Am Heart Assoc
Background The burden of cancer in heart failure with reduced ejection fraction is
apparently growing. Randomized controlled trials (RCTs) may help understanding this …

Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights …

W Ouwerkerk, THK Teng, J Tromp… - European journal of …, 2020 - Wiley Online Library
Background Angiotensin‐converting enzyme inhibitors (ACEi)/angiotensin receptor blockers
(ARB) and β‐blockers are guideline‐recommended first‐line therapies in heart failure (HF) …

Heart failure with mid-range ejection fraction

PK Srivastava, JJ Hsu, B Ziaeian… - Current heart failure reports, 2020 - Springer
Heart Failure With Mid-range Ejection Fraction | Current Heart Failure Reports Skip to main
content SpringerLink Account Menu Find a journal Publish with us Track your research Search …

Increased long-term mortality in women with high left ventricular ejection fraction: data from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical …

C Gebhard, M Maredziak, M Messerli… - European Heart …, 2020 - academic.oup.com
Aims There are significant sex-specific differences in left ventricular ejection fraction (LVEF),
with a higher LVEF being observed in women. We sought to assess the clinical relevance of …